GKOS
Glaukos Corporation (GKOS)
$
88About Glaukos Corporation (GKOS)
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA.
Details
Daily high
$151.12
Daily low
$142.01
Price at open
$142.01
52 Week High
$151.12
52 Week Low
$74.74
Market cap
8.3B
Dividend yield
0.00%
Volume
1.1M
Avg. volume
627,724
P/E ratio
-50.94
Glaukos Corporation News
Details
Daily high
$151.12
Daily low
$142.01
Price at open
$142.01
52 Week High
$151.12
52 Week Low
$74.74
Market cap
8.3B
Dividend yield
0.00%
Volume
1.1M
Avg. volume
627,724
P/E ratio
-50.94